194 related articles for article (PubMed ID: 18571119)
21. Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia.
Schinner S; Kempf K; Overmann H; Willenberg HS; Schott M; Rose B; Scherbaum WA; Herder C
Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S64-9. PubMed ID: 18777458
[TBL] [Abstract][Full Text] [Related]
22. Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats.
Rodríguez A; Catalán V; Becerril S; Gil MJ; Mugueta C; Gómez-Ambrosi J; Frühbeck G
Life Sci; 2008 Oct; 83(15-16):540-9. PubMed ID: 18761357
[TBL] [Abstract][Full Text] [Related]
23. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.
Takamura T; Misu H; Matsuzawa-Nagata N; Sakurai M; Ota T; Shimizu A; Kurita S; Takeshita Y; Ando H; Honda M; Kaneko S
Obesity (Silver Spring); 2008 Dec; 16(12):2601-9. PubMed ID: 18846047
[TBL] [Abstract][Full Text] [Related]
24. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients.
Salmenniemi U; Zacharova J; Ruotsalainen E; Vauhkonen I; Pihlajamäki J; Kainulainen S; Punnonen K; Laakso M
J Clin Endocrinol Metab; 2005 Jul; 90(7):4216-23. PubMed ID: 15855264
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular actions of adiponectin: pathophysiologic implications.
Maia-Fernandes T; Roncon-Albuquerque R; Leite-Moreira AF
Rev Port Cardiol; 2008 Nov; 27(11):1431-49. PubMed ID: 19227810
[TBL] [Abstract][Full Text] [Related]
26. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
Kawano J; Arora R
J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516
[TBL] [Abstract][Full Text] [Related]
27. Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: insulin resistance and type 2 diabetes mellitus candidate genes.
Bermúdez VJ; Rojas E; Toledo A; Rodríguez-Molina D; Vega K; Suárez L; Pacheco M; Canelón R; Arráiz N; Rojas J; Velasco M
Am J Ther; 2013; 20(4):414-21. PubMed ID: 23656997
[TBL] [Abstract][Full Text] [Related]
28. Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes.
Carpentier AC
Diabetes Metab; 2008 Apr; 34(2):97-107. PubMed ID: 18353699
[TBL] [Abstract][Full Text] [Related]
29. Elevated free fatty acids and impaired adiponectin bioactivity contribute to reduced SOD2 protein in monocytes of type 2 diabetes patients.
Bauer S; Wanninger J; Neumeier M; Wurm S; Weigert J; Kopp A; Bala M; Schäffler A; Aslanidis C; Buechler C
Exp Mol Pathol; 2011 Feb; 90(1):101-6. PubMed ID: 21035442
[TBL] [Abstract][Full Text] [Related]
30. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
[TBL] [Abstract][Full Text] [Related]
31. Adiponectin oligomers and ectopic fat in liver and skeletal muscle in humans.
Kantartzis K; Staiger H; Machann J; Schick F; Claussen CD; Machicao F; Fritsche A; Häring HU; Stefan N
Obesity (Silver Spring); 2009 Feb; 17(2):390-2. PubMed ID: 19169222
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
33. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
34. Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetes.
Singh AK; Joharapurkar AA; Khan MP; Mishra JS; Singh N; Yadav M; Hossain Z; Khan K; Kumar S; Dhanesha NA; Mishra DP; Maurya R; Sharma S; Jain MR; Trivedi AK; Godbole MM; Gayen JR; Chattopadhyay N; Sanyal S
Diabetes; 2014 Oct; 63(10):3530-44. PubMed ID: 24848063
[TBL] [Abstract][Full Text] [Related]
35. Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes.
Weigert J; Neumeier M; Wanninger J; Wurm S; Kopp A; Schober F; Filarsky M; Schäffler A; Zeitoun M; Aslanidis C; Buechler C
FEBS Lett; 2008 May; 582(12):1777-82. PubMed ID: 18442481
[TBL] [Abstract][Full Text] [Related]
36. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
Shih CC; Lin CH; Lin WL; Wu JB
J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
[TBL] [Abstract][Full Text] [Related]
37. Adiponectin and adiponectin receptors in obesity-linked insulin resistance.
Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K
Novartis Found Symp; 2007; 286():164-76; discussion 176-82, 200-3. PubMed ID: 18269182
[TBL] [Abstract][Full Text] [Related]
38. The association studies of ADIPOQ with type 2 diabetes mellitus in Chinese populations.
Li Y; Yang Y; Shi L; Li X; Zhang Y; Yao Y
Diabetes Metab Res Rev; 2012 Oct; 28(7):551-9. PubMed ID: 22539443
[TBL] [Abstract][Full Text] [Related]
39. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.
Kadowaki T; Yamauchi T; Kubota N
FEBS Lett; 2008 Jan; 582(1):74-80. PubMed ID: 18054335
[TBL] [Abstract][Full Text] [Related]
40. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
